Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia

Clinical trial NCT00626483 · COMPLETED

Trial details

NCT number

NCT00626483

Sponsor

Gary Archer Ph.D.

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2007-04-24

Primary completion

2016-07-06

Enrollment

34

View on ClinicalTrials.gov